Literature DB >> 14630450

Vaccination and autoimmune disease: what is the evidence?

David C Wraith1, Michel Goldman, Paul-Henri Lambert.   

Abstract

As many as one in 20 people in Europe and North America have some form of autoimmune disease. These diseases arise in genetically predisposed individuals but require an environmental trigger. Of the many potential environmental factors, infections are the most likely cause. Microbial antigens can induce cross-reactive immune responses against self-antigens, whereas infections can non-specifically enhance their presentation to the immune system. The immune system uses fail-safe mechanisms to suppress infection-associated tissue damage and thus limits autoimmune responses. The association between infection and autoimmune disease has, however, stimulated a debate as to whether such diseases might also be triggered by vaccines. Indeed there are numerous claims and counter claims relating to such a risk. Here we review the mechanisms involved in the induction of autoimmunity and assess the implications for vaccination in human beings.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630450     DOI: 10.1016/S0140-6736(03)14802-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  56 in total

Review 1.  Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target.

Authors:  Arne Taxt; Rein Aasland; Halvor Sommerfelt; James Nataro; Pål Puntervoll
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

2.  Acquired factor VIII haemophilia following influenza vaccination.

Authors:  Guillaume Moulis; Grégory Pugnet; Haleh Bagheri; Claire Courtellemont; Antoine Huart; Dominique Chauveau; Jacques Pourrat; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2010-06-27       Impact factor: 2.953

3.  Autoimmune diseases after adolescent or adult immunization: what should we expect?

Authors:  Claire-Anne Siegrist
Journal:  CMAJ       Date:  2007-11-20       Impact factor: 8.262

Review 4.  Autoimmune therapies targeting costimulation and emerging trends in multivalent therapeutics.

Authors:  Chuda Chittasupho; Teruna J Siahaan; Charlotte M Vines; Cory Berkland
Journal:  Ther Deliv       Date:  2011-07

5.  Comprehensive analysis of patients with neuromyelitis optica spectrum disorder (NMOSD) combined with chronic hepatitis B (CHB) infection and seropositive for anti-aquaporin-4 antibody.

Authors:  Jia Liu; Li Xu; Zhuo-Lin Chen; Min Li; Huan Yi; Fu-Hua Peng
Journal:  Bosn J Basic Med Sci       Date:  2018-02-20       Impact factor: 3.363

6.  Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study.

Authors:  Edeltraut Garbe; Frank Andersohn; Elisabeth Bronder; Abdulgabar Salama; Andreas Klimpel; Michael Thomae; Hubert Schrezenmeier; Martin Hildebrandt; Ernst Späth-Schwalbe; Andreas Grüneisen; Oliver Meyer; Hanife Kurtal
Journal:  Eur J Clin Pharmacol       Date:  2011-12-21       Impact factor: 2.953

7.  [Vaccination under immunosuppressive therapy of chronic inflammatory diseases].

Authors:  M Weisser
Journal:  Internist (Berl)       Date:  2011-03       Impact factor: 0.743

8.  Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis.

Authors:  Marloes W Heijstek; Gecilmara C S Pileggi; Evelien Zonneveld-Huijssoon; Wineke Armbrust; Esther P A H Hoppenreijs; Cuno S P M Uiterwaal; Wietse Kuis; Nico M Wulffraat
Journal:  Ann Rheum Dis       Date:  2007-02-06       Impact factor: 19.103

9.  Two-year follow-up of the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Registry.

Authors:  Enrique P Gurfinkel; Ricardo Leon de la Fuente
Journal:  Tex Heart Inst J       Date:  2004

Review 10.  The key role of genomics in modern vaccine and drug design for emerging infectious diseases.

Authors:  Kate L Seib; Gordon Dougan; Rino Rappuoli
Journal:  PLoS Genet       Date:  2009-10-26       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.